Mark Lappe
Chief Executive Officer at Inhibrx Biosciences · 9 reported transactions in 1 company · latest trade Oct 14, 2026
Their record
No purchases old enough to measure yet.
Their trades
Bought | Oct 14, 2026 | Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days. | ||
Bought | Oct 14, 2026 | Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days. | ||
Bought | Oct 14, 2026 | Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days. | ||
Bought | Oct 14, 2026 | Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days. | ||
Bought | Oct 14, 2026 | Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days. | ||
Bought | Sep 28, 2026 | Sep 28, 2026 close $101.71 → Oct 29, 2026 close $73.65. S&P 500 +0.9% over the same days. | ||
Bought | Sep 28, 2026 | Sep 28, 2026 close $101.71 → Oct 29, 2026 close $73.65. S&P 500 +0.9% over the same days. | ||
Bought | Sep 25, 2026 | Sep 25, 2026 close $99.61 → Oct 29, 2026 close $73.65. S&P 500 +0.1% over the same days. | ||
Bought | Sep 25, 2026 | Sep 25, 2026 close $99.61 → Oct 29, 2026 close $73.65. S&P 500 +0.1% over the same days. |
BoughtInhibrx Biosciences
$208.3K
Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days.
BoughtInhibrx Biosciences
$205.9K
Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days.
BoughtInhibrx Biosciences
$8.6K
Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days.
BoughtInhibrx Biosciences
$209.9K
Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days.
BoughtInhibrx Biosciences
$207.7K
Oct 14, 2026 close $85.26 → Oct 29, 2026 close $73.65. S&P 500 +0.3% over the same days.
BoughtInhibrx Biosciences
$305.1K
Sep 28, 2026 close $101.71 → Oct 29, 2026 close $73.65. S&P 500 +0.9% over the same days.
BoughtInhibrx Biosciences
$148.3K
Sep 28, 2026 close $101.71 → Oct 29, 2026 close $73.65. S&P 500 +0.9% over the same days.
BoughtInhibrx Biosciences
$216.7K
Sep 25, 2026 close $99.61 → Oct 29, 2026 close $73.65. S&P 500 +0.1% over the same days.
BoughtInhibrx Biosciences
$328.6K
Sep 25, 2026 close $99.61 → Oct 29, 2026 close $73.65. S&P 500 +0.1% over the same days.